Lupus & antiphospholipid syndrome

Aberrant sphingosine-1-phosphate receptor 1 expression on activated naive B cells associated with disease activity and lupus nephritis in systemic lupus erythematosus

Arthritis Res TherPublished Mechanistic study

Authors' conclusion

Surface S1PR1 expression was downregulated in aNAV and DN2 B cells. Clinically, decreased surface S1PR1 expression on aNAV B cells was significantly correlated with active status, increased disease activity, LN involvement, and elevated ESR.

Study context

Population
Patients with systemic lupus erythematosus (SLE); Peripheral blood mononuclear cells (PBMCs) assessed for S1PR1 expression in B cell subsets and plasma cells
Participants
49 patients
Outcome
S1PR1 expression in B cell subsets and plasma cells

Main finding

As reported in the abstract

  • Intracellular S1PR1 expression significantly increased across all B cell subsets (rNAV, activated naive (aNAV), SWM, USM, DN1, DN2) and antibody-secreting cells (ASCs)
  • Surface S1PR1 downregulated in aNAV and DN2 B cells, upregulated in ASCs
  • Surface S1PR1 downregulation on aNAV B cells significantly associated with active disease status, SLEDAI-2K scores and Lupus Nephritis (LN) involvement

Further findings

Inflammatory markers vs surface S1PR1 expression

IL-6, IL-8 and C3c levels showed no correlation with surface S1PR1 expression
Erythrocyte sedimentation rate (ESR) showed a significant negative correlation

Surface CXCR3 expression

Lupus aNAV and DN2 B cells had reduced surface CXCR3 without correlation to S1PR1 expression
Other B cell subsets in SLE showed significant correlation between CXCR3 and S1PR1 expression

Original publication

Aberrant sphingosine-1-phosphate receptor 1 expression on activated naive B cells associated with disease activity and lupus nephritis in systemic lupus erythematosus. Arthritis Res Ther. Published 14 May 2026. doi:10.1186/s13075-026-03829-3

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.